| Novartis Pharma Schweiz AG - Certican 0.25 mg, dispergierbare Tabletten |
| 56239 | | 01 | | Certican 0.25 mg | | dispergierbare Tabletten | | L04AA18 | | Everolimus | | 21.04.2005 | | |
|
| Composition |
| everolimusum 0.25 mg, antiox.: E 321, excipiens pro compresso. |
| Packungsbestandteile |
| Dispersible Tablets | | | | | | Active Agent | Dose |
|---|
| Everolimus | 0.25 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 321 | | antiox. |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
